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Background: Available evidence that compares outcomes from laparoscopic and open surgery 
for colorectal cancer shows no difference in disease free or survival time, or in health-related 
quality of life outcomes, but does not capture the short term benefits of laparoscopic methods 
in the early postoperative period.
Aim: To explore the cost-effectiveness of laparoscopic colorectal surgery, compared to open 
methods, using quality of life data gathered in the first 6 weeks after surgery.
Methods: Participants were recruited in 2006–2007 in a district general hospital in the south 
of England; those with a diagnosis of cancer or polyps were included in the analysis. Quality 
of life data were collected using EQ-5D, on alternate days after surgery for 4 weeks. Costs 
per patient, from a National Health Service perspective (in British pounds, 2006) comprised 
the sum of operative, hospital, and community costs. Missing data were filled using multiple 
imputation methods. The difference in mean quality adjusted life years and costs between sur-
gery groups were estimated simultaneously using a multivariate regression model applied to 
20 imputed datasets. The probability that laparoscopic surgery is cost-effective compared to open 
surgery for a given societal willingness-to-pay threshold is illustrated using a cost-effectiveness 
acceptability curve.
Results: The sample comprised 68 laparoscopic and 27 open surgery patients. At 28 days, the 
incremental cost per quality adjusted life year gained from laparoscopic surgery was £12,375. 
At a societal willingness-to-pay of £30,000, the probability that laparoscopic surgery is cost-
effective, exceeds 65% (at £20,000 ≈60%). In sensitivity analyses, laparoscopic surgery remained 
cost-effective compared to open surgery, provided it results in a saving £699 in hospital bed 
days and takes no more than 8 minutes longer to perform.
Conclusion: The study provides formal evidence of the cost-effectiveness of laparoscopic 
approaches and supports current guidelines that promote use of laparoscopy where suitably 
trained surgeons are available.
Keywords: colorectal cancer, laparoscopy, cost-effectiveness, QALYs
Introduction
Within the British National Health Service (NHS), laparoscopic resection is rec-
ommended by the National Institute for Health and Care Excellence (NICE) as an 
alternative to open surgery for people with colorectal cancer for whom both methods 
would be considered suitable, and if performed by a trained surgeon.1 A health technol-
ogy assessment suggested that laparoscopic surgery was associated with higher costs, 
but was no more effective than open surgery. Savings from shorter hospital stays after 
laparoscopic procedures did not fully offset higher operation costs and conversions to 
open methods due to complications.1 Research concludes that there is no significant 
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difference in disease free or overall survival at 3 years,1,2 or 
in health-related quality of life outcomes.3–6 However, few 
studies capture the short term benefits of laparoscopic surgery 
in the early postoperative period.1,7
The technology assessment concluded that, at the 
£30,000 cost per quality adjusted life year (QALY) threshold,8 
laparoscopic surgery would need to result in a gain of 
0.009–0.010 QALY to be considered cost-effective, com-
pared to open surgery.1,2 A study was undertaken to explore 
the QALY differences in the early postoperative recovery 
period,9 and costs.10 This paper reports the cost-effectiveness 
analysis that brings together the QALY and cost data for those 
patients who had a diagnosis of cancer or polyps. Helped 
by the National Training Programme for Laparoscopic 
Colorectal Surgery (LAPCO), the uptake of laparoscopic 
surgery has increased in NHS hospitals, but it is still used in 
the minority of cases (40% in 2012).11 Providing evidence 
on cost-effectiveness may encourage increased training of 
surgeons and wider use of laparoscopic methods.12
Methods
Participants
Consecutive patients requiring elective colorectal resections 
(over 18 years, without endometriosis, able to give consent) 
in a district general hospital in south England were invited 
to join the study, 2006–2007. Patients were allocated to lap-
aroscopic or open surgery by administrative staff, depending 
on availability of clinic appointments, or, in some cases, 
requests from referring general practitioners.
Data collection
Following informed consent, baseline demographic informa-
tion (sex, age, operation type [right or left side resection], 
American Society of Anesthesiologists (ASA) physical status 
score) was collected pre-operatively. Patients were followed 
for 6 weeks after surgery. A micro-costing study gathered 
treatment costs (operative, in-hospital stay, community), in 
British pounds, 2006, as described in full elsewhere.10 Quality 
of life data were collected using EuroQol 5D-3L instrument 
(EQ-5D). The five domains (mobility, self-care, usual activi-
ties, pain/discomfort, anxiety/depression) are scored on three 
levels (1, no problem; 2, some problem; 3, serious/extreme 
problem/unable) giving a theoretical maximum of 243 differ-
ent health states which are converted to single index utility 
values (range -0.59 for score 33333 to 1.0 [perfect health] 
for score 11111), using UK tariff tables.13–15 Participants were 
asked to complete EQ-5D on alternate days after surgery for 
4 weeks, and at the end of the fifth and sixth week (total of 
16 times), in a diary that was returned at the 6 week outpatient 
follow-up clinic appointment.
sample
Among 201 patients (131 laparoscopic, 70 open) recruited, 
129 (64.2%) had a diagnosis of cancer or polyps (85 laparo-
scopic, 44 open). The sample was reduced to 98 (70 laparo-
scopic, 28 open) by exclusion of patients undergoing a rectal 
resection because such procedures (which typically result in 
higher costs and lower QALY due to requiring a stoma),7,10 
were unevenly distributed between the groups (n=15, 17.6% 
laparoscopic; n=16, 36.4% open). A further three patients 
were lost because missing data were too extensive to be 
imputed. Hence, the final sample included in the analysis 
was 95 (68 laparoscopic, 27 open), of which 17 (18.0%) 
had a diagnosis of polyps, rather than cancer; 14 (20.6%) of 
laparoscopic procedures, 3 (11.1%) of open.
analysis
Data were imported into STATA12 (Stata Statistical Software, 
release 12; StataCorp LP, College Station, TX, USA). Base-
line characteristics of groups were compared. Costs and 
quality of life data were assessed for missing data. Since it 
was found that a complete case analysis would reduce the 
sample to 43, and result in exclusion of some participants 
with complete EQ-5D or cost data, multiple imputation 
(Monte Carlo simulation) was used to generate missing 
values.16 It was not possible to impute stable quality of life 
estimates up to 42 days, so the analysis focused on the first 
28 days after surgery (14 EQ-5D scores).
An area under the curve (AUC) method was employed to 
generate a QALY value for each patient. Differences in mean 
QALYs and costs between surgery groups were estimated 
simultaneously using a multivariate regression model applied 
to 20 imputed datasets with EQ-5D at baseline, sex, age, and 
operation type (left, right side) included as covariates. ASA 
score was strongly correlated with the EQ-5D baseline score 
and therefore not included as a covariate. A cost-effectiveness 
ellipse and cost-effectiveness acceptability curve (CEAC) 
were produced to indicate the probability that laparoscopic 
surgery is cost-effective compared to open for a given societal 
willingness-to-pay (WTP) threshold. Sensitivity analyses 
were performed.
Ethical considerations
A favorable ethical opinion was obtained prior to starting the 
research from the South West Surrey Local Research Ethics 
Committee (study 05/Q1909/74), and the hospital Research 
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and Development Committee. All participants gave informed 
consent prior to inclusion in the study.
Results
There were no statistically significant differences between 
groups at baseline (Table 1). The multiple imputation regres-
sion estimates (Table 2) show the cost of the laparoscopic 
operations was £1,037 higher than open (P,0.005), due to 
equipment costs; staff costs were £190 lower (P=0.039) due to a 
shorter operating time (Table 3). The open group had a longer 
mean length of hospital stay (Table 3) and incurred £897 higher 
bed day costs (P=0.007) compared to laparoscopic. Commu-
nity costs were low in both groups. There was no significant 
difference in the total costs between the groups because the 
higher laparoscopic surgery costs were offset by shorter lengths 
of stay. Compared to those undergoing open surgery, patients in 
the laparoscopic group gained an average of 0.011207 QALYs 
over the first 28 days after surgery (95% confidence intervals 
0.006 to 0.016) (Table 2 and Figure 1).
Cost-effectiveness
At 28 days, the overall incremental cost-effectiveness ratio 
(ICER), calculated as the difference in adjusted mean costs 
divided by the difference in adjusted mean QALYs, and 
showing the cost per QALY gained from laparoscopic, 
compared to open surgery, was £12,375. Uncertainty in 
the ICER point estimates are represented, using confidence 
intervals, on the cost-effectiveness plane (CEP) (Figure 2). 
The cost-effectiveness ellipse is centered in the top right 
quadrant, indicating that laparoscopic surgery is more costly 
and more effective than open. The confidence intervals of the 
ellipse overlap the bottom right quadrant where laparoscopic 
is dominant (less costly and more effective than open). The 
line bisecting the top right and lower left quadrants shows 
the threshold cost-effectiveness line, based on a WTP of 
£20,000. The point estimate ICER lies below this threshold, 
demonstrating laparoscopic surgery as cost-effective.
The CEAC illustrates the probability that laparoscopic 
treatment will be deemed cost-effective at different societal 
WTP per QALY gained (Figure 3). At 28 days, the CEAC 
indicates that, at WTP of £30,000, the probability that lap-
aroscopic surgery will be cost-effective, compared to open 
methods, exceeds 65% (and this is also illustrated by the 
proportion of the 95% confidence interval below the thresh-
old line in Figure 2). At a WTP of £20,000, the probability 
is approaching 60%.
sensitivity analysis
The costs of equipment and supplies, operative medical 
staff, hospital bed days, and community costs were varied 
independently of one another between the minimum and 
maximum values of their 95% confidence intervals whilst 
all other variables were held constant at their mean point 
estimates. At their lowest level, where costs were most 
favorable toward laparoscopic surgery, the resulting ICERs 
were all dominant in favor of the laparoscopic procedure. 
Where the differences in costs were considered at their 
highest (in favor of open), the result was less clear. With 
operative staff costs and community costs at their highest 
level, laparoscopic surgery still appeared cost-effective at 
Table 1 Baseline comparison of groups
Characteristic Laparoscopic, N=68 Open, N=27 Significant 
differencen % n %
sex
 Male 35 51.5 12 44.4 P=0.66^
 Female 33 48.5 15 55.6
Operation type
 Right 32 47.1 16 59.3 P=0.18^
 left 36 52.9 11 40.7
n Mean SD n Mean SD
age
 Years 68 72.6 11.4 27 71.9 10.6 P=0.66#
asa score
 1–3 (worst) 68 2.2 0.7 27 2.1 0.7 P=0.14^
EQ-5D
 -0.59 to 1.00 47 0.83 0.17 21 0.82 0.18 P=0.83#
Notes: ^Chi-square test; #Mann–Whitney U test.
Abbreviations: asa, american society of anesthesiologists; sD, standard deviation; EQ-5D, EuroQol 5 Dimension, 3 level.
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a WTP threshold of £30,000 (with costs per QALY gained 
of £28,385, and £17,219 respectively). When costs of 
equipment and supplies were at their highest level compared 
to open (£,1477 more expensive), the resulting ICER of 
£34,690 was marginally outside the cost-effective level; 
the turning point was £1,424. At its most expensive, where 
laparoscopic surgery achieved a reduction in hospital bed 
days costing only £247 compared to open, an ICER of 
£70,332 was realized. The threshold, where an ICER of 
£30,000 was achieved, was at a bed day cost reduction 
of £699; the mean cost reduction for bed days seen in the 
data exceeded this at £897.
Varying the estimated difference in QALY between the 
lower (0.00603) and upper (0.01638) 95% confidence interval 
values had no effect on the cost-effectiveness at a WTP of 
£30,000, achieving ICER ranging from £22,994 to £8,466.
Staff operative costs were lower in the laparoscopic 
group, reflecting a shorter operation time by mean of 
47 minutes, (which equates to a theatre staff and overhead 
cost of £169). Operation times may vary with surgeon 
experience and style, and have typically been shown to be 
higher in laparoscopic procedures than open.18 Given the 
mean difference in QALYs (0.011207) and costs (£139) 
observed in this study, laparoscopic operation time could be 
increased by 55 minutes (£197), ie, 8 minutes longer than 
open, with all other factors held constant, and still achieve 
an ICER £30,000.
Discussion
This is the first cost-effectiveness analysis comparing 
laparoscopic and open colorectal surgery for colorectal 
resections to incorporate quality of life differences in 
the early postoperative recovery period. Whilst previous 
studies, based on longer follow-up periods, suggest no 
difference in outcomes between laparoscopic and open 
surgery,3–6 this study provides robust evidence of improved 
health-related quality of life outcomes associated with lap-
aroscopy in the first 6 weeks post-surgery, and demonstrates 
the cost-effectiveness of that approach, compared to open 
methods. Improved health-related quality of life after lap-
aroscopic surgery has been associated with less blood loss, 
better immune and inflammatory responses, less pain and 
analgesic requirements, faster postoperative recovery of 
bowel function, food intake, and physical activity.17,18
Quality of life in this study was measured earlier in the 
recovery period and more intensively than in most other 
Table 2 Cost (£, 2006) and QalY differences between groups
Unadjusted group means Adjusted* group differences (laparoscopic – open)
Lapar- 
oscopic
Open Mean  
difference
Standard  
error
P 95% confidence interval
Lower Upper
Operation costs
 Equipment, supplies 1,582.31 382.40 1,226.68 121.48 ,0.0005 976.60 1,476.75
 Medical staff 496.79 690.52 -189.72 87.76 0.039 -369.14 -10.29
 Total 2,079.10 1,072.92 1,036.96 166.36 ,0.0005 696.71 1,377.21
hospital
 Bed days 1,582.51 2,486.76 -896.68 326.74 0.007 -1,546.21 -247.15
Community
 gP, nurse, a&E etc 124.74 127.77 -1.58 27.30 0.954 -55.87 52.70
Total costs 3,786.35 3,687.45 138.70 389.33 0.723 -636.92 914.32
EQ-5D/QalYs 0.10114 0.09052 0.011207 0.00260 ,0.0005 0.00603 0.01638
Note: *Controlling for baseline EQ-5D score, age, sex, type of operation.
Abbreviations: QalY, quality adjusted life year; gP, general Practitioner; a&E, accident and Emergency; EQ-5D,  EuroQol 5 Dimension, 3 level.
Table 3 group comparison of operation time and length of hospital stay
Laparoscopic Open Difference  
(open – laparoscopic)
Mann–Whitney 
U test  
Pn Mean SD n Mean SD Mean 95% confidence 
intervals
Duration of surgery (minutes) 49 108.3 35.4 12 155.4 67.8 47.2 3.4  90.9 0.0071
length of hospital stay (days) 64 4.00 2.64 27 6.15 2.52 2.15 0.97 3.33 ,0.0005
Abbreviation: sD, standard deviation.
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studies comparing laparoscopic and open methods for 
colo rectal surgery. Moreover, the EQ-5D instrument was used 
to enable the calculation of QALYs so that a cost-effectiveness 
analysis could be undertaken. Health-related quality of life 
in most other studies has been measured using a variety of 
different generic and disease-specific instruments,4,5 and at 
later time points post-surgery, making direct comparison of 
the findings of different studies problematical.
The analysis reported in this paper is based on those 
patients with a diagnosis of cancer or polyps in a larger study 
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of patients undergoing colorectal surgery at a district general 
hospital in England,9 ie, some 65% of the whole sample, 
(47% cancer, 18% polyps). Consistent with the parent study 
(which included those with a diagnosis other than cancer or 
polyps, and rectal resections)10 and other evidence,19,20 the 
overall costs of laparoscopic and open approaches for this 
subgroup were not significantly different, with higher opera-
tion costs (due to instrumentation) for the laparoscopic group 
largely offset by a shorter length of hospital stay.
The results demonstrate a significant QALY gain for lap-
aroscopic surgery, compared to open, of 0.011207 at 28 days, 
which was similar to that observed for the whole sample in 
the parent study.7 This QALY gain exceeds that identified 
by the NICE technology assessment panel (0.009–0.010) as 
being required in order to deem laparoscopic surgery cost-
effective for colorectal cancer.1,2 In the cost-effectiveness 
analysis, the point estimate cost per QALY gained was 
£12,375. The probabilistic approach to analyze the uncer-
tainty demonstrated that the laparoscopic procedure was close 
to clear dominance over open surgery and cost-effective at a 
WTP below the current threshold set by NICE.8 The current 
guideline from NICE11 is that no fixed WTP will be enforced, 
although the 2004 guidance was that a plausible threshold is 
£20,000–£30,000. The sensitivity analysis showed the results 
to be relatively robust to variation in the main input variables. 
Only the cost of hospital stay was independently capable of 
shifting the ICER to a level above £30,000, but at bed day 
savings associated with laparoscopic below those recorded 
in this study. The deterministic sensitivity analysis showed 
laparoscopic surgery to be cost-effective with operation times 
up to 8 minutes longer than open.
This study has several limitations. The sample of cancer/
polyp patients was drawn from a larger study of all patients 
undergoing colorectal resection, and statistical power was 
lost because the numbers in this subset was small. The sample 
size was further eroded by the removal of rectal resections, 
which was done to avoid bias due to the disproportionate 
number of rectal resections in the open group. There is no 
reason to believe that the imbalance was due to any factor 
other than chance. However, the lack of randomization of 
patients to study groups is a drawback. Administrative staff, 
who were unconnected to the study were responsible for 
assigning patients to surgical teams at the point of referral 
by general practitioners. Allocation was based on pragmatic 
factors, such as availability of appointments, but this is not 
a good substitute for randomization.
The proportion of patients with a diagnosis of polyps, 
rather than cancer, was higher in the laparoscopic group than 
the open group (20.6% versus 11.1%). Since the postoperative 
recovery of patients with cancer is potentially different from 
that of patients with polyps, we tested whether the sample 
imbalance might affect the results, by adding a diagnosis 
variable (cancer versus polyps) to the regression modelling. 
Whilst this affected the coefficients by a very small amount, 
the diagnosis covariate was not significant (P.0.5), indicating 
that it had no material effect on the findings.
The study was affected by missing data. Operative costs 
were based on observation and researchers had not been 
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present during all surgeries.10 Some participants, particularly 
those with higher ASA grades at baseline, longer hospital 
stays and in higher intensity units,7 had not provided qual-
ity of life data. Even using multiple imputation, it was not 
possible to extend the analysis from 28 to 42 days, due 
to missing information. Multiple imputation was used in 
preference to a complete case analysis which would have 
reduced the sample size further. The impact of uncertainty 
in the sample data was accommodated in the sensitivity 
analysis and found to have little impact on the conclusions 
of the study. The results of the analysis using the imputed 
data sets were checked against those generated by a complete 
case analysis. The latter found laparoscopic surgery to be 
£258 more expensive, on average, than open (versus £139 
using multiple imputation), and achieving a QALY gain of 
0.013523 (versus 0.011207); ICER point estimate of £19,106 
(versus £12,375).
The costs used were those collected at a base year of 
2006. No adjustment for inflation has been made, and in 
nominal terms the results may overstate the significance of 
the findings. Since that time, the relative cost of the disposable 
instruments (a major item for the laparoscopic procedure) 
may have fallen due to increased uptake and advancements 
in technology. The cost of hospital stays (predominantly 
affecting the open group) has increased, but hospital policies 
for earlier discharge may have offset this to some extent. 
Rising staff costs will have affected both groups similarly. 
The study only focused on the first 6 weeks after surgery, 
and no subsequent follow-up of patients was conducted. 
This was because prior research had demonstrated no dif-
ferences in survival or health-related quality of life in the 
longer term,1–6 and the research design deliberately focused 
on the early postoperative period where a gap in evidence 
had been identified.1,7
Conclusion
This study provides formal evidence of the cost-effectiveness 
of laparoscopic approaches based on quality of life gains, 
compared to open methods, in the early postoperative period. 
The findings support current guidelines that promote the use 
of laparoscopy where suitably trained surgeons are available.1 
The National Training Programme LAPCO is enabling more 
hospitals to offer minimally invasive surgery options and 
patients to reap the benefits of faster recovery.21
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